• Mon news: Ventyx gets boost from Sanofi. PhRMA IRA legal challenge gets new life. AZ breast cancer drug disappoints. Teva’s once-monthly schizophrenia med. AZ gets FDA approval for first self-administered flu vaccine. See more on our front page

Transferring Duane in CV?!

anonymous

Guest
How could Novartis be so dumb and transfer Duane to another department?! They laid off got reps in April. But they choose to keep an incompetent idiot like Duane who destroyed CV? Duane and Vas destroyed CV. Yet those morons still have a job. Vas bought Leqvio for 9.5 billion and it’s a failed drug
 

<



How could Novartis be so dumb and transfer Duane to another department?! They laid off got reps in April. But they choose to keep an incompetent idiot like Duane who destroyed CV? Duane and Vas destroyed CV. Yet those morons still have a job. Vas bought Leqvio for 9.5 billion and it’s a failed drug

Cut Duane some slack, as he turned giving away $3,500.00 syringes into an art form.
His brilliance when it came to costing Novartis money and then firing the reps for it cannot be understated.
Throw in his eloquent Q&A in Dallas and you have the makings of a true leader.
It should be a fun ride for the reps over in renal.
 








Cut Duane some slack, as he turned giving away $3,500.00 syringes into an art form.
His brilliance when it came to costing Novartis money and then firing the reps for it cannot be understated.
Throw in his eloquent Q&A in Dallas and you have the makings of a true leader.
It should be a fun ride for the reps over in renal.


how can you people look at yourselves in the mirror selling entresto? what a joke, a fifth grader can look at the trials and see that generic valsartan by itself beats out entresto. Novartis can't attract anything but post docs, the caliber of the people doing research is appalling.
 




how can you people look at yourselves in the mirror selling entresto? what a joke, a fifth grader can look at the trials and see that generic valsartan by itself beats out entresto. Novartis can't attract anything but post docs, the caliber of the people doing research is appalling.
You are truly a dipshit. The trial you’re referring to didn’t even look at Entresto’s indication. How about pulling up a PI and reading what it actually does. Or better yet, talk to the patients it’s helped. Go home troll.
 




Similar threads

Replies
6
Views
2K
Novartis
anonymous
Replies
100
Views
14K
Replies
9
Views
2K
Novartis
anonymous
Replies
25
Views
4K